LIST OF BINDING INTERFACES for query 'BETA-GALACTOSIDASE' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
3thd	DGJ	Migalastat (DB05018)	Migalastat is an alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant.	BETA-GALACTOSIDASE (Homo sapiens)	BetaGal_dom4_5 Glyco_hydro_35	3THD_A_DGJA900	Details
4d1j	DGJ	Migalastat (DB05018)	Migalastat is an alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant.	BETA-GALACTOSIDASE, PUTATIVE, BGL35A (Cellvibrio japonicus)	DUF5597 Glyco_hydro_42	4D1J_A_DGJA600	Details
6tsh	DGJ	Migalastat (DB05018)	Migalastat is an alpha-galactosidase A chaperone used for the treatment of Fabry disease in patients with an amenable galactosidase alpha gene (GLA) variant.	BETA-GALACTOSIDASE (Escherichia coli)	Bgal_small_N DUF4981 Glyco_hydro_2 Glyco_hydro_2_C Glyco_hydro_2_N	6TSH_A_DGJA3002	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["3thd","DGJ","Migalastat (DB05018)","Homo sapiens","BETA-GALACTOSIDASE","BetaGal_dom4_5;Glyco_hydro_35"],["4d1j","DGJ","Migalastat (DB05018)","Cellvibrio japonicus","BETA-GALACTOSIDASE, PUTATIVE, BGL35A","DUF5597;Glyco_hydro_42"],["6tsh","DGJ","Migalastat (DB05018)","Escherichia coli","BETA-GALACTOSIDASE","Bgal_small_N;DUF4981;Glyco_hydro_2;Glyco_hydro_2_C;Glyco_hydro_2_N"]]